Literature DB >> 17054980

Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency.

Kirsten Hoyer1, Maike Krenz, Jeffrey Robbins, Joanne S Ingwall.   

Abstract

Cardiac-specific transgenesis in the mouse is widely used to study the basic biology and chemistry of the heart and to model human cardiovascular disease. A fundamental difference between mouse and human hearts is the background motor protein: mouse hearts contain predominantly the alphaalpha-myosin heavy chain (MyHC) isozyme while human hearts contain predominantly the betabeta-MyHC isozyme. Although the intrinsic differences in mechanical and enzymatic properties of the alphaalpha- and betabeta-MyHC molecules are well known, the consequences of isozyme shifts on energetics of the intact beating heart remain unknown. Therefore, we compared the free energy of ATP hydrolysis (|DeltaG( approximately ATP)|) determined by (31)P-NMR spectroscopy in isolated perfused littermate mouse hearts containing the same amount of myosin comprised of either >95% alphaalpha-MyHC or approximately 83% betabeta-MyHC. |DeltaG( approximately ATP)| was approximately 2 kJ mol(-1) higher in the betabeta-MyHC hearts at all workloads. Furthermore, upon inotropic challenge, hearts containing predominantly betabeta-MyHC hearts increased developed pressure more than alphaalpha-MyHC hearts whereas heart rate increased more in alphaalpha-MyHC hearts. Thus, hearts containing predominantly the betabeta-MyHC isozyme are more energy efficient than alphaalpha-MyHC hearts. We suggest that these fundamental differences in the motor protein energy efficiency at the whole heart level should be considered when interpreting results using mouse-based cardiovascular modeling of normal and diseased human hearts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054980      PMCID: PMC4412927          DOI: 10.1016/j.yjmcc.2006.08.116

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  35 in total

Review 1.  Is the failing heart energy starved? On using chemical energy to support cardiac function.

Authors:  Joanne S Ingwall; Robert G Weiss
Journal:  Circ Res       Date:  2004-07-23       Impact factor: 17.367

2.  Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

Authors:  Briar R Ertz-Berger; Huamei He; Candice Dowell; Stephen M Factor; Todd E Haim; Sara Nunez; Steven D Schwartz; Joanne S Ingwall; Jil C Tardiff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

3.  Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences.

Authors:  E M McNally; R Kraft; M Bravo-Zehnder; D A Taylor; L A Leinwand
Journal:  J Mol Biol       Date:  1989-12-05       Impact factor: 5.469

4.  Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro.

Authors:  P VanBuren; D E Harris; N R Alpert; D M Warshaw
Journal:  Circ Res       Date:  1995-08       Impact factor: 17.367

5.  Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.

Authors:  Norman R Alpert; Saidi A Mohiddin; Dorothy Tripodi; Jacqueline Jacobson-Hatzell; Kelly Vaughn-Whitley; Christine Brosseau; David M Warshaw; Lameh Fananapazir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-04       Impact factor: 4.733

6.  Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.

Authors:  E Kiss; G Jakab; E G Kranias; I Edes
Journal:  Circ Res       Date:  1994-08       Impact factor: 17.367

Review 7.  Molecular mechanisms of inherited cardiomyopathies.

Authors:  Diane Fatkin; Robert M Graham
Journal:  Physiol Rev       Date:  2002-10       Impact factor: 37.312

8.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.

Authors:  I Rayment; H M Holden; J R Sellers; L Fananapazir; N D Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Shortening velocity and myosin and myofibrillar ATPase activity related to myosin isoenzyme composition during postnatal development in rat myocardium.

Authors:  V Cappelli; R Bottinelli; C Poggesi; R Moggio; C Reggiani
Journal:  Circ Res       Date:  1989-08       Impact factor: 17.367

10.  ATPase activity of myosin correlated with speed of muscle shortening.

Authors:  M Bárány
Journal:  J Gen Physiol       Date:  1967-07       Impact factor: 4.086

View more
  16 in total

Review 1.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

2.  Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.

Authors:  Ron Rice; Pia Guinto; Candice Dowell-Martino; Huamei He; Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2009-12-31       Impact factor: 5.000

3.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

4.  Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific.

Authors:  Huamei He; Kirsten Hoyer; Hai Tao; Ronald Rice; Jesus Jimenez; Jil C Tardiff; Joanne S Ingwall
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

5.  Transmural variation in myosin heavy chain isoform expression modulates the timing of myocardial force generation in porcine left ventricle.

Authors:  Julian E Stelzer; Holly S Norman; Peter P Chen; Jitandrakumar R Patel; Richard L Moss
Journal:  J Physiol       Date:  2008-09-11       Impact factor: 5.182

6.  Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.

Authors:  Shuang-Qing Chen; Pei-Jun Wang; Gao-Jun Ten; Wei Zhan; Ming-Hua Li; Feng-Chao Zang
Journal:  Dement Geriatr Cogn Disord       Date:  2010-01-06       Impact factor: 2.959

7.  Cardioselective dominant-negative thyroid hormone receptor (Delta337T) modulates myocardial metabolism and contractile efficiency.

Authors:  Outi M Hyyti; Aaron K Olson; Ming Ge; Xue-Han Ning; Norman E Buroker; Youngran Chung; Thomas Jue; Michael A Portman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-03       Impact factor: 4.310

Review 8.  Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Authors:  Brian C Jensen; Timothy D OʼConnell; Paul C Simpson
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

9.  Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha.

Authors:  Weiqun Shen; Dorothy E Vatner; Stephen F Vatner; Joanne S Ingwall
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

10.  R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts.

Authors:  Huamei He; Maryam M Javadpour; Farhana Latif; Jil C Tardiff; Joanne S Ingwall
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.